文献速递关节外科

初次全膝关节置换局部应用妥布霉素和万古霉素可达到急性假体周围感染常见细菌的最低抑菌浓度

Local delivery of tobramycin and vancomycin in primary total knee arthroplasty achieves minimum inhibitory concentrations for common bacteria causing acute prosthetic joint infection.
PubMed 文献 · Bone Joint J · 2020-01-01

该研究回顾性分析2014至2019年初次全膝关节置换后90天内因急性假体周围感染行翻修术的19例患者,获得29株细菌,其中31%对庆大霉素耐药、34%对妥布霉素耐药、24%对万古霉素耐药。前瞻性研究显示,将2.4g妥布霉素手工混入80g骨水泥及1g万古霉素粉剂关节内应用,可持续达到敏感菌的最低抑菌浓度。

要点

  • 初次全膝关节置换后急性假体周围感染细菌中约三分之一对氨基糖苷类耐药,约四分之一对万古霉素耐药。
  • 除一株梭杆菌外,对妥布霉素耐药的细菌均对万古霉素敏感,反之亦然。
  • 2.4g妥布霉素混入80g骨水泥联合1g万古霉素粉剂可达到敏感菌最低抑菌浓度。

核心结论

  • 初次全膝关节置换后急性假体周围感染细菌中约三分之一对骨水泥中常混合的氨基糖苷类耐药,约四分之一对万古霉素耐药。
  • 除一株梭杆菌外,对妥布霉素耐药的细菌均对万古霉素敏感,反之亦然。
  • 妥布霉素混入抗生素骨水泥联合万古霉素粉剂可为大多数急性假体周围感染细菌提供最佳覆盖。

研究设计与样本

  • 回顾性单中心数据库分析2014年1月1日至2019年5月7日所有初次全膝关节置换术,筛选初始术后90天内因急性假体周围感染行翻修术的患者。
  • 对翻修时阳性培养获得的细菌进行庆大霉素、妥布霉素和万古霉素药敏试验。
  • 前瞻性研究检测初次全膝关节置换术后第一天关节内抗生素浓度,采用五种局部抗生素递送策略之一,将妥布霉素和/或万古霉素混入聚甲基丙烯酸甲酯或万古霉素粉剂。

主要发现

  • 共识别19例初次全膝关节置换术后急性假体周围感染患者,分离出29株独特细菌。
  • 平均翻修时间为37天(范围6至84天)。
  • 9株(31%)对庆大霉素耐药,10株(34%)对妥布霉素耐药,7株(24%)对万古霉素耐药。
  • 除一株梭杆菌对三种抗生素均耐药外,所有对妥布霉素或庆大霉素耐药的细菌均对万古霉素敏感,反之亦然。
  • 2.4g妥布霉素手工混入80g聚甲基丙烯酸甲酯及1g关节内万古霉素粉剂持续达到敏感菌的最低抑菌浓度。

关键数值与推荐

  • 急性假体周围感染定义为初次全膝关节置换术后90天内行翻修术。
  • 2.4g妥布霉素手工混入80g聚甲基丙烯酸甲酯联合1g关节内万古霉素粉剂可持续达到敏感菌的最低抑菌浓度。

临床怎么用

  • 对于初次全膝关节置换后急性假体周围感染,可考虑将妥布霉素混入抗生素骨水泥联合万古霉素粉剂以覆盖常见致病菌。
  • 因约三分之一细菌对氨基糖苷类耐药、约四分之一对万古霉素耐药,单一药物覆盖可能不足。

局限性

  • 回顾性单中心数据库分析,样本量有限(19例患者,29株细菌)。
  • 前瞻性研究仅检测术后第一天关节内抗生素浓度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The aim of this study was to determine if the local delivery of vancomycin and tobramycin in primary total knee arthroplasty (TKA) can achieve intra-articular concentrations exceeding the minimum inhibitory concentration thresholds for bacteria causing acute prosthetic joint infection (PJI). METHODS: Using a retrospective single-institution database of all primary TKAs performed between January 1 2014 and May 7 2019, we identified patients with acute PJI that were managed surgically within 90 days of the initial procedure. The organisms from positive cultures obtained at the time of revision were tested for susceptibility to gentamicin, tobramycin, and vancomycin. A prospective study was then performed to determine the intra-articular antibiotic concentration on postoperative day one after primary TKA using one of five local antibiotic delivery strategies with tobramycin and/or vancomycin mixed into the polymethylmethacrylate (PMMA) or vancomycin powder. RESULTS: A total of 19 patients with acute PJI after TKA were identified and 29 unique bacterial isolates were recovered. The mean time to revision was 37 days (6 to 84). Nine isolates (31%) were resistant to gentamicin, ten (34%) were resistant to tobramycin, and seven (24%) were resistant to vancomycin. Excluding one Fusobacterium nucleatum, which was resistant to all three antibiotics, all isolates resistant to tobramycin or gentamicin were susceptible to vancomycin and vice versa. Overall, 2.4 g of tobramycin hand-mixed into 80 g of PMMA and 1 g of intra-articular vancomycin powder consistently achieved concentrations above the minimum inhibitory concentrations of susceptible organisms. CONCLUSION: One-third of bacteria causing acute PJI after primary TKA were resistant to the aminoglycosides commonly mixed into PMMA, and one-quarter were resistant to vancomycin. With one exception, all bacteria resistant to tobramycin were susceptible to vancomycin and vice versa. Based on these results, the optimal cover for organisms causing most cases of acute PJI after TKA can be achieved with a combination of tobramycin mixed in antibiotic cement, and vancomycin powder. Cite this article: Bone Joint J 2020;102-B(6 Supple A):163-169.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Lawrie CM, Jo S, Barrack T, et al. Local delivery of tobramycin and vancomycin in primary total knee arthroplasty achieves minimum inhibitory concentrations for common bacteria causing acute prosthetic joint infection. Bone Joint J. 2020. PMID: 32475280. doi:10.1302/0301-620X.102B6.BJJ-2019-1639.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。